Wednesday, January 26, 2022 12:15 AM
ST. LOUIS—The Canadian Association of Optometrists
(CAO) has endorsed the World Council of Optometry
(WCO) myopia management as standard of care
resolution. In a position statement
, the CAO said that it supports the WCO resolution and endorses evidence-based myopia management as a standard of care for all at-risk patients. The CAO recognizes that myopia is a global public health issue and cannot be considered merely an inconvenience of uncorrected vision. CAO president Dr. Harry Bohnsack said, “Since the World Health Organization’s release of the World Report on Vision in 2019, CAO’s Council has been concerned about the increasing prevalence of myopia globally.
Tuesday, January 25, 2022 12:15 AM
, a leader in specialty contact lens technology, has established an exclusive distribution agreement with EyePrint Prosthetics
, according to an announcement Monday. The alliance enables SynergEyes to offer the ScanFitPRO lens, which combines elevation specific technology with exciting new developments in the field of ocular topographical scanning, to its customers and their patients. The new partnership was announced at the 2022 Global Specialty Lens Symposium (GSLS) in Las Vegas. SynergEyes is planning to commercialize the SynergEyes ScanFitPRO lens in the third quarter of 2022.
Monday, January 24, 2022 12:21 AM
SOPHIA ANTIPOLIS, France—Nicox SA
(Euronext Paris: FR0013018124, COX), an international ophthalmology company, reported net revenue of €3.5 million for the fourth quarter of 2021 ended Dec. 31, 2021, versus net revenue of €5.8 million for the fourth quarter of 2020.
Monday, January 24, 2022 12:18 AM
MIAMI—On Jan. 21, 1962, Bascom Palmer Eye Institute
, the University of Miami Miller School of Medicine Department of Ophthalmology, officially opened its doors as the first center in the southeastern U.S. devoted exclusively to the study and treatment of the eye.
Friday, January 21, 2022 12:27 AM
LAVAL, QC—Bausch Health Companies
has announced that Dr. Yehia Hashad will join Bausch + Lomb Corp.
as executive vice president of research & development (R&D) and chief medical officer (CMO), effective Jan. 31.
Friday, January 21, 2022 12:21 AM
COLUMBIA, Md.—The Foundation Fighting Blindness
announced the promotion of Jason Menzo to president and chief operating officer, effective immediately.
Thursday, January 20, 2022 12:24 AM
NORTH CHICAGO, Ill.—Allergan
, an AbbVie
(NYSE: ABBV) company, announced this week a series of executive changes within the leadership of its eyecare group.
Thursday, January 20, 2022 12:18 AM
SAN DIEGO—Eyes On Eyecare
has announced that registration is officially open for Eyes On Dry Eye 2022. The three-day virtual educational summit is scheduled for March 4-6, 2022.
Wednesday, January 19, 2022 12:15 AM
WICHITA, Kan.—Organizers of the Envision Conference through Envision University are excited to return to an in-person conference experience in 2022 with outstanding programs and opportunities for professionals in the vision rehabilitation field.
Tuesday, January 18, 2022 12:24 AM
ST. LOUIS—The American Optometric Association’s
(AOA) nationwide public awareness campaign is making waves and reinforcing the essential care doctors of optometry deliver.
Tuesday, January 18, 2022 12:21 AM
, a UnitedHealth Group (NYSE: UNH) company, said it will invest in new ways to help children and adults across the country reduce their exposure to blue light and support their overall eye health, amid ongoing use of screens during COVID-19 and the greater reliance on remote school and work.
Tuesday, January 11, 2022 1:11 PM
January is Glaucoma Awareness Month, and Bausch + Lomb
released new data from a survey of glaucoma patients to better understand the impact of hyperemia in their glaucoma treatment and lives. The survey, which was conducted in partnership with the Glaucoma Research Foundation
, uncovered the emotional and social cost of hyperemia on glaucoma patients, the impact hyperemia has on treatment adherence and the need for conversations between patients and their eyecare professionals to find the right treatment option for them.
Tuesday, January 11, 2022 12:21 AM
(SIX/NYSE: ALC) yesterday announced the closing of its previously announced acquisition of Ivantis
, developer of the novel Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients in connection with cataract surgery.